Smoking cessation decreases arterial blood pressure in hypertensive smokers: A subgroup analysis of the randomized controlled trial GENTSMOKING

被引:5
|
作者
Gaya, Patricia, V [1 ]
Fonseca, Guilherme Wesley P. [2 ]
Tanji, Lucas Tsuyoshi [3 ]
Abe, Tania O. [1 ]
Alves, Maria Janieire N. N. [4 ]
Santos, Paulo Caleb Junior de Lima [5 ]
Colombo, Fernanda M. Consolim [6 ]
Scholz, Jaqueline R. [1 ]
机构
[1] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Programa Prevencao, Rua Dr Eneas de Carvalho Aguiar 44 1 Andar Bloco 2, BR-05403000 Sao Paulo, Brazil
[2] Univ Sao Paulo, Escola Educ Fis & Esporte, Sao Paulo, Brazil
[3] Univ Sao Paulo, Fac Med FMUSP, Sao Paulo, Brazil
[4] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Inst Coracao, Sao Paulo, Brazil
[5] Univ Sao Paulo, Dept Farmacol, Escola Paulista Med, Sao Paulo, Brazil
[6] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Unidade Hipertensao, Sao Paulo, Brazil
来源
TOBACCO INDUCED DISEASES | 2024年 / 22卷
基金
巴西圣保罗研究基金会;
关键词
blood pressure smoking; cessation hypertension; management; CIGARETTE-SMOKING; HEART-RATE; RISK;
D O I
10.18332/tid/186853
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
INTRODUCTION High blood pressure in hypertensive smokers is affected by nicotine consumption. This study aimed to evaluate the effect of smoking cessation treatments on blood pressure in hypertensive smokers. METHODS A total of 113 hypertensive smokers on antihypertensives during smoking cessation treatment in the randomized controlled trial GENTSMOKING were considered for analysis. At Baseline (T0) and Week 12 (T12), systolic and diastolic blood pressure (SBP and DBP), and heart rate (HR) were measured using a semiautomated digital oscillometric device. Mean arterial pressure (MAP) and delta differences for SBP, DBP, HR, and MAP were calculated. Smoking cessation was confirmed by measuring carbon monoxide (CO) in exhaled air. RESULTS After 12 weeks of treatment, 72 participants ceased smoking (cessation group) and 41 did not (no cessation group). At T0, there was no statistically meaningful difference between groups with respect to age, body mass index, CO, and daily cigarette consumption. At T12, daily cigarette consumption and CO had decreased in both groups (p<0.001). The cessation group showed decreased SBP (131 +/- 2 vs 125 +/- 2 mmHg, p=0.00 4), DBP (79 +/- 1 vs 77 +/- 1 mmHg, p=0.031), MAP (96 +/- 1 vs 93 +/- 1 mmHg, p=0.005), and HR (79 +/- 1 vs 74 +/- 1 beats/min, p=0.001), and increased body weight (77.4 +/- 2.1 vs 79.2 +/- 2.2 kg, p<0.001). No significant differences were seen for these variables in the no cessation group. Decrease in blood pressure was significantly higher among hypertensive participants with SBP >= 130 mmHg: SBP (145 +/- 2 vs 132 +/- 2 mmHg, p<0.001), DBP (85 +/- 2 vs 80 +/- 1 mmHg, p=0.002), MAP (105 +/- 1 vs 97 +/- 1 mmHg, p<0.001), and HR (81 +/- 2 vs 74 +/- 2 beats/min, p=0.002). A positive correlation was found between HR and CO (r=0.34; p=0.001). CONCLUSIONS Smoking cessation treatment reduced blood pressure in hypertensive smokers, allowing them to reach therapeutic targets for hypertension management. Smoking cessation has a positive impact on hypertension treatment; therefore, it should be encouraged in clinical practice.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Pilot randomized controlled trial of an internet-based smoking cessation intervention for pregnant smokers ('MumsQuit')
    Herbec, Aleksandra
    Brown, Jamie
    Tombor, Ildiko
    Michie, Susan
    West, Robert
    DRUG AND ALCOHOL DEPENDENCE, 2014, 140 : 130 - 136
  • [22] A Randomized, Controlled Trial of Financial Incentives for Smoking Cessation
    Volpp, Kevin G.
    Troxel, Andrea B.
    Pauly, Mark V.
    Glick, Henry A.
    Puig, Andrea
    Asch, David A.
    Galvin, Robert
    Zhu, Jingsan
    Wan, Fei
    DeGuzman, Jill
    Corbett, Elizabeth
    Weiner, Janet
    Audrain-McGovern, Janet
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (07): : 699 - 709
  • [23] Effects of electronic cigarettes on smoking cessation in smokers with no plans to quit: A randomized placebo-controlled trial
    Foulds, Jonathan
    Cobb, Caroline
    Yen, Miao-Shan
    Veldheer, Susan
    Brosnan, Phoebe
    Yingst, Jessica
    Hrabovsky, Shari
    Lopez, Alexa
    Allen, Sophia
    Bullen, Christopher
    Sciamanna, Chris
    Eissenberg, Thomas
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2021, 28 (SUPPL 1) : S186 - S186
  • [24] RANDOMIZED, CONTROLLED TRIAL OF TRANSDERMAL CLONIDINE FOR SMOKING CESSATION
    HILLEMAN, DE
    MOHIUDDIN, SM
    DELCORE, MG
    LUCAS, BD
    ANNALS OF PHARMACOTHERAPY, 1993, 27 (09) : 1025 - 1028
  • [25] Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial
    Brody, Arthur L.
    Zorick, Todd
    Hubert, Robert
    Hellemann, Gerhard S.
    Balali, Shabnam
    Kawasaki, Sarah S.
    Garcia, Lizette Y.
    Enoki, Ryutaro
    Abraham, Paul
    Young, Paulina
    McCreary, Charles
    NICOTINE & TOBACCO RESEARCH, 2017, 19 (01) : 68 - 76
  • [27] A randomized controlled trial of financial incentives for smoking cessation
    Volpp, KG
    Levy, AG
    Asch, DA
    Berlin, JA
    Murphy, JJ
    Gomez, A
    Sox, H
    Zhu, JS
    Lerman, C
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (01) : 12 - 18
  • [28] Financial incentives for smoking cessation in low-income smokers: study protocol for a randomized controlled trial
    Jean-François Etter
    Trials, 13
  • [29] THE IMPACT OF SMOKING AND SMOKING CESSATION ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE
    Gepner, Adam D.
    Piper, Megan
    Korcarz, Claudia
    Hansen, Kristin
    Weber, JoAnne
    Baker, Timothy
    Fiore, Michael
    Stein, James
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2023 - 2023
  • [30] Design and participant characteristics of a randomized-controlled trial of telemedicine for smoking cessation among rural smokers
    Mussulman, Laura
    Ellerbeck, Edward F.
    Cupertino, A. Paula
    Preacher, Kristopher J.
    Spaulding, Ryan
    Catley, Delwyn
    Cox, Lisa Sanderson
    Lambart, Leah
    Hunt, Jamie J.
    Nazir, Niaman
    Shireman, Theresa
    Richter, Kimber P.
    CONTEMPORARY CLINICAL TRIALS, 2014, 38 (02) : 173 - 181